Cerebros Neurosciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 17-07-2024
- Paid Up Capital ₹ 0.20 M
as on 17-07-2024
- Company Age 28 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 29.35 Cr
as on 17-07-2024
- Satisfied Charges ₹ 8.10 M
as on 17-07-2024
- Revenue -16.15%
(FY 2022)
- Profit -37.60%
(FY 2022)
- Ebitda -51.88%
(FY 2022)
- Net Worth 30.66%
(FY 2022)
- Total Assets -17.47%
(FY 2022)
About Cerebros Neurosciences
The Corporate was formerly known as Keyur Developers Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹29.35 Cr. The company has closed loans amounting to ₹8.10 M, as per Ministry of Corporate Affairs (MCA) records.
Krishnakant Patel, Labhuben Patel, Megha Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U74110GJ1996PTC028650
- Company No.
028650
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cerebros Neurosciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnakant Patel  | Director | 22-Jan-1996 | Current |
| Keyur Patel | Director | 05-Apr-2017 | Current |
| Labhuben Patel | Director | 22-Jan-1996 | Current |
| Megha Patel | Director | 05-Apr-2017 | Current |
Financial Performance and Corporate Structure Insights of Cerebros Neurosciences.
Cerebros Neurosciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.15% decrease. The company also saw a substantial fall in profitability, with a 37.6% decrease in profit. The company's net worth Soared by an impressive increase of 30.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cerebros Neurosciences?
In 2021, Cerebros Neurosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Health1 Neuro1 Super Speciality Hospital Private LimitedActive 3 years 5 monthsKrishnakant Patel, Labhuben Patel and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Aug 2021 | ₹29.35 Cr | Open |
Others Creation Date: 27 Sep 2019 | ₹8.10 M | Satisfied |
How Many Employees Work at Cerebros Neurosciences?
Unlock and access historical data on people associated with Cerebros Neurosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cerebros Neurosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cerebros Neurosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
